LLY - Eli Lilly Magnite leads the premarket losers' pack
Torchlight Energy Resources (TRCH) -15% on business combination timingRubius Therapeutics (RUBY) -14% on initial data for RTX-240 in solid tumorsEntera Bio (ENTX) -13%.Nova LifeStyle (NVFY) -12%.NLS Pharmaceutics (NLSP) -12%.Eli Lilly and Company (LLY) -7% after Lilly’s Alzheimer's data fail to impress Wall Street; Savara climbs on Oppenheimer initiation in pre-market analyst action.Magnite (MGNI) -7% after launching $350M convertible notes offering.Hepion Pharmaceuticals (HEPA) -7%.GigaMedia (GIGM) -6%.Second Sight Medical Products (EYES) -6%.Regulus Therapeutics (RGLS) -6%.PDS Biotechnology (PDSB) -5%.Seelos Therapeutics (SEEL) -5%.AmpliTech Group (AMPG) -5%.
For further details see:
Eli Lilly, Magnite leads the premarket losers' pack